Quantbot Technologies LP Immunic, Inc. Transaction History
Quantbot Technologies LP
- $3.55 Billion
- Q2 2025
Shares
3 transactions
Others Institutions Holding IMUX
# of Institutions
64Shares Held
50.1MCall Options Held
13.2KPut Options Held
60.6K-
Abrdn PLC8.24MShares$5.77 Million0.01% of portfolio
-
Bvf Inc San Francisco, CA7.65MShares$5.36 Million0.21% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT7.29MShares$5.11 Million0.4% of portfolio
-
Avidity Partners Management LP Dallas, TX5.62MShares$3.93 Million1.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.13MShares$2.89 Million0.0% of portfolio
About IMMUNIC, INC.
- Ticker IMUX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,565,000
- Market Cap $21.4M
- Description
- Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...